Stockman Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,631
| Closed | -$277K | – | 208 |
|
|
2023
Q1 | $277K | Hold |
3,631
| – | – | 0.06% | 165 |
|
|
2022
Q4 | $301K | Hold |
3,631
| – | – | 0.07% | 147 |
|
|
2022
Q3 | $288K | Hold |
3,631
| – | – | 0.08% | 139 |
|
|
2022
Q2 | $270K | Hold |
3,631
| – | – | 0.07% | 156 |
|
|
2022
Q1 | $326K | Hold |
3,631
| – | – | 0.07% | 151 |
|
|
2021
Q4 | $407K | Sell |
3,631
-4
| -0.1% | -$448 | 0.08% | 137 |
|
|
2021
Q3 | $457K | Hold |
3,635
| – | – | 0.1% | 121 |
|
|
2021
Q2 | $492K | Hold |
3,635
| – | – | 0.12% | 112 |
|
|
2021
Q1 | $493K | Hold |
3,635
| – | – | 0.14% | 106 |
|
|
2020
Q4 | $512K | Hold |
3,635
| – | – | 0.16% | 96 |
|
|
2020
Q3 | $405K | Hold |
3,635
| – | – | 0.15% | 98 |
|
|
2020
Q2 | $407K | Hold |
3,635
| – | – | 0.15% | 104 |
|
|
2020
Q1 | $281K | Hold |
3,635
| – | – | 0.12% | 108 |
|
|
2019
Q4 | $346K | Sell |
3,635
-610
| -14% | -$58.1K | 0.12% | 121 |
|
|
2019
Q3 | $324K | Sell |
4,245
-35
| -0.8% | -$2.67K | 0.12% | 120 |
|
|
2019
Q2 | $375K | Hold |
4,280
| – | – | 0.15% | 105 |
|
|
2019
Q1 | $388K | Sell |
4,280
-600
| -12% | -$54.4K | 0.17% | 100 |
|
|
2018
Q4 | $350K | Hold |
4,880
| – | – | 0.17% | 99 |
|
|
2018
Q3 | $468K | Buy |
4,880
+95
| +2% | +$9.11K | 0.2% | 91 |
|
|
2018
Q2 | $455K | Buy |
4,785
+940
| +24% | +$89.4K | 0.21% | 88 |
|
|
2018
Q1 | $337K | Sell |
3,845
-115
| -3% | -$10.1K | 0.15% | 106 |
|
|
2017
Q4 | $336K | Buy |
+3,960
| New | +$336K | 0.15% | 105 |
|